生物
小核仁RNA
胶质瘤
DNA甲基化
甲基化
基因
基因沉默
癌症研究
基因签名
长非编码RNA
计算生物学
基因表达
遗传学
核糖核酸
作者
Xiaoyu Yue,Yinfei Zheng,Lianxin Li,Zhihao Yang,Zhigang Chen,Yu Wang,Zhiwei Wang,Deran Zhang,Erbao Bian,Bing Zhao
出处
期刊:Epigenomics
[Future Medicine]
日期:2022-09-01
卷期号:14 (18): 1089-1104
被引量:3
标识
DOI:10.2217/epi-2022-0272
摘要
Aim: To explore the prognostic value of methylated snoRNA genes in glioma and construct a prognostic risk signature. Materials & methods: We retrieved clinical information and 450K methylation data from The Cancer Genome Atlas and obtained five methylated snoRNA genes. Then we established a risk signature and verified the effect of SNORA71B on glioma cells with functional assays. Results: A risk signature containing five methylated snoRNA genes was constructed and demonstrated to be an independent predictor of glioma prognosis. Silencing SNORA71B restrained the proliferation, migration and invasion of glioma cells and reduced the expression of mesenchymal and cell cycle marker proteins. Conclusion: This study constructed a methylated snoRNA gene risk signature, which may provide a reference for glioma patients' prognosis assessment.
科研通智能强力驱动
Strongly Powered by AbleSci AI